Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics

  1. Andisheh Abedini
  2. Annette Plesner
  3. Ping Cao
  4. Zachary Ridgway
  5. Jinghua Zhang
  6. Ling-Hsien Tu
  7. Chris T Middleton
  8. Brian Chao
  9. Daniel J Sartori
  10. Fanling Meng
  11. Hui Wang
  12. Amy G Wong
  13. Martin T Zanni
  14. C Bruce Verchere
  15. Daniel P Raleigh  Is a corresponding author
  16. Ann Marie Schmidt  Is a corresponding author
  1. New York University School of Medicine, United States
  2. Novo Nordisk, Denmark
  3. Stony Brook University, United States
  4. PhaseTech Spectroscopy, Inc., United States
  5. University of Wisconsin-Madison, United States
  6. University of British Columbia, Canada
1 additional file

Additional files

All additional files

Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.

https://cdn.elifesciences.org/articles/12977/elife-12977-supp-v2.zip

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Andisheh Abedini
  2. Annette Plesner
  3. Ping Cao
  4. Zachary Ridgway
  5. Jinghua Zhang
  6. Ling-Hsien Tu
  7. Chris T Middleton
  8. Brian Chao
  9. Daniel J Sartori
  10. Fanling Meng
  11. Hui Wang
  12. Amy G Wong
  13. Martin T Zanni
  14. C Bruce Verchere
  15. Daniel P Raleigh
  16. Ann Marie Schmidt
(2016)
Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
eLife 5:e12977.
https://doi.org/10.7554/eLife.12977